The Oncology Institute, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US68236X1000
USD
3.23
0.27 (9.12%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryCompany CV
About The Oncology Institute, Inc. stock-summary
stock-summary
The Oncology Institute, Inc.
Pharmaceuticals & Biotechnology
DFP Healthcare Acquisitions Corp. is a blank check company. The Company’s business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. It focuses on identifying a target business in the healthcare or healthcare-related industries in the United States and other developed countries. The Company focuses its investment effort across the entire healthcare industry, which encompasses services, therapeutics, devices, diagnostics and animal health.
Company Coordinates stock-summary
Company Details
780 Third Avenue , NEW YORK NY : 10017
stock-summary
Tel: 1 212 5511600
stock-summary
stock-summary
Registrar Details
stock-recommendation Shareholding
Shareholding Snapshotstock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Domestic Funds

Domestic Funds

Held in 6 Schemes (16.52%)

Foreign Institutions

Held by 15 Foreign Institutions (3.06%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summary Board of Directorsstock-summary
Management
Designation
stock-recommendation Stock DNA
Revenue and Profits:
Net Sales:
120 Million
(Quarterly Results - Jun 2025)
Net Profit:
-14 Million
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

USD 304 Million (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

-5.75

stock-summary
Return on Equity

522.19%

stock-summary
Price to Book

-33.82